Vanadium and diabetes

BioFactors

Volumn 10, Issue 1, 1999, Pages 43-51

  Thompson, Katherine H ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; VANADIUM;

ARTICLE; COMPLEX FORMATION; DIABETES CONTROL; DIABETES MELLITUS; DRUG ABSORPTION; DRUG ACTIVITY; DRUG EFFECT; DRUG UPTAKE; GLUCOSE TRANSPORT; HUMAN; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

MAMMALIA;

EID: 0032730741     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520100105     Document Type: Article

References (85)

1. A. Butler and C.J. Carrano, Coordination chemistry of vanadium in biological systems, Coord. Chem. Rev. 109 (1991), 61-105.
2. D.C. Crans, Aqueous chemistry of labile oxovanadates: relevance to biological studies, Comments Inorg. Chem. 16 (1994), 1-33.
3. N.D. Chasteen, J.K. Grady and C.E. Holloway, Characterization of the binding, kinetics, and redox stability of vanadium (IV) and vanadium (V) protein complexes in serum, Inorg. Chem. 25 (1986), 2754-2760.
4. D. Rehder, The bioinorganic chemistry of vanadium, Angew. Chem. Int. Ed. Engl. 30 (1991), 148-167.
5. R. Wever and K. Kustin, Vanadium: a biologically relevant element, Adv. Inorg. Chem. 35 (1990), 81-115.
6. I.G. Macara, Vanadium - an element in search of a role, Trends Biochem. Sci. 5 (1980), 92-94.
7. F.H. Nielsen and E.O. Uthus, The essentiality and metabolism of vanadium, in: Vanadium in Biological Systems, N.D. Chasteen, ed., Kluwer Academic Publishers, Dordrecht, the Netherlands, 1990, pp. 51-62.
8. B.R. Nechay, Mechanisms of action of vanadium, Ann. Rev. Pharmacol. Toxicol. 24 (1984), 501-524.
9. A.R. Byrne and L. Kosta, Vanadium in foods and humans, Sci. Total Envir. 10 (1978), 17-30.
10. L.L. Hopkins, Jr. and H.E. Mohr, Vanadium as an essential nutrient, Fed. Proc. 33 (1974), 1773-1775.
11. H. Illing-Gunther, M. Anke, M. Muller, A. Trupschuch and S. Anke, Biological importance, analysis and supply of vanadium, in: Trace Elements in Man and Animals - 9: Proceedings of the Ninth International Symposium on Trace Elements in Man and Animals, P.W.F. Fischer, M. L'Abbe, K.A. Cockell and R.S. Gibson, eds, Banff, Alberta, Canada: NRC Research Press, Ottawa, Canada, 1997, pp. 179-180.
12. F.H. Nielsen, Vanadium in mammalian physiology and nutrition, in: Vanadium and Its Role in Life, H. Sigel and A. Sigel, eds, Vol. 31, Marcel Dekker, Inc., New York, NY, 1995, pp. 543-574.
13. B. Venugopal and T.D. Luckey, Chemical toxicity of metals and metalloids, in: Metal Toxicity in Mammals, Vol. 2, Plenum Press, New York, NY, 1978, pp. 220-227.
14. G. Elberg, Z. He, J. Li, N. Sekar and Y. Shechter, Vanadate activates membranous nonreceptor protein tyrosine kinase in rat adipocytes, Diabetes 46 (1997), 1684-1690.
15. G. Huyer, S. Liu, J. Kelly, J. Moffat, P. Payette, B. Kennedy, G. Tsaprailis, M.J. Gresser and C. Ramachandran, Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate, J. Biol. Chem. 272 (1997), 843-851.
16. J.A. Gordon, Use of vanadate as protein-phosphotyrosine phosphatase inhibitor, Meth. Enzymol. 201 (1991), 477-482.
17. M.J. Clague and A. Butler, On the mechanism of cis-dioxovanadium(V)-catalyzed oxidation of bromide by hydrogen peroxide: evidence for a reactive, binuclear vanadium(V) peroxo complex, J. Am. Chem. Soc. 117 (1995), 3474-3484.
18. F.H. Nielsen, Vanadium deprivation alters the changes in plasma thyroid hormone concentrations, pancreatic amylase activity, and serum lactate dehydrogenase activity in the BB rat caused by increasing dietary iodine, FASEB J. 11 (1997), A148.
19. G.E. Lienhard, J.W. Slot, D.E. James and M.M. Mueckler, How cells absorb glucose, Sci. Amer. 267 (1992), 86-91.
20. C.R. Kahn and M.F. White, The insulin receptor and the molecular mechanism of insulin action, J. Clin. Invest. 82 (1988), 1151-1154.
21. M.P. Czech, Molecular basis of insulin action, Ann. Rev. Biochem. 46 (1977), 359-384.
22. M.F White, S.E. Shaleson, H. Keutmann and C.R. Kahn, A cascade of tyrosine autophosphorylation in the beta-subunit activates the phosphotransferase of the insulin receptor, J. Biol. Chem. 263 (1988), 2962-2972.
23. C.J. Smith and O.M. Rosen, Mechanism of action of insulin, in: Diabetes Mellitus: Theory and Practice, M. Ellenberg and M. Rifkin, eds, 3rd edn, McGraw Hill, Toronto, ON, 1983, pp. 89-96.
24. A.M. Coulston, Nutritional considerations in the control of diabetes mellitus, Nutrition Today (January/February) (1994), 6-11.
25. S.P. Wolff, Z.Y. Jiang and J.V. Hunt, Protein glycation and oxidative stress in diabetes mellitus and ageing, Free Rad. Biol. and Med. 10 (1991), 339-352.
26. E.L. Tolman, E. Barris, M. Burns, A. Pansisni and R. Partridge, Effects of vanadium on glucose metabolism in vitro, Life Sci. 25 (1979), 1159-1164.
27. Y. Shechter and S.J.D. Karlish, Insulin-like stimulation of glucose oxidation in rat adipocytes by vanadyl (IV) ions, Nature (London) 284 (1980), 556-558.
28. G.R. Dubyak and A. Kleinzeller, The insulin mimetic effect of vanadate in isolated rat adipocytes, J. Biol. Chem. 255 (1980), 5306-5312.
29. H. Degani, M. Gochin, S.J.D. Karlish and Y. Shechter, Electron paramagnetic resonance studies and insulin-like effects of vanadium in rat adipocytes, Biochemistry 20 (1981), 5795-5799.
30. W.C. Duckworth, S.S. Solomon, J. Liepnieks, F.G. Hamel, S. Hand and D.E. Peavy, Insulin-like effects of vanadate in isolated rat adipocytes, Endocrinology 122 (1988), 2285-2289.
31. N. Okumura and T. Shimazu, Vanadate stimulates D-glucose transport into sarcolemmal vesicles from rat skeletal muscle, J. Biochem. (Tokyo) 112 (1992), 107-111.
32. J.J. Hajjar, M.P. Dobish and T.K. Tomicic, Effect of acute and chronic vanadate administration on sugar transport in rat jejunum, Proc. Soc. Exp. Biol. Med. 190 (1989), 35-41.
33. G.L. Kellett and E.D. Barker, The effect of vanadate on glucose transport and metabolism in rat small intestine, Biochim. Biophys. Acta 979 (1989), 311-315.
34. K.L. Madsen, V.M. Porter and R.N. Fedorak, Oral vanadate reduces Na-dependent glucose transport in rat small intestine, Diabetes 42 (1993), 1126-1132.
35. M.R. Paquet, R.J. Romanek and R.J. Sargeant, Vanadate induces the recruitment of GLUT-4 glucose transporter to the plasma membrane of rat adipocytes, Mol. Cell. Biochem. 109 (1992), 149-155.
36. K.G. Mountjoy and J.S. Flier, Vanadate regulates glucose transporter (GLUT-1) expression NIH 3T3 mouse fibroblasts, Endocrinology 127 (1990), 2025-2034.
37. H.V. Strout, P.P. Vicario, C. Biswas, R. Saperstein, E.J. Brady, P.F. Pilch and J. Berger, Vanadate treatment of streptozotocin diabetic rats restores expression of the insulin-responsive glucose transporter in skeletal muscle, Endocrinology 126 (1990), 2728-2732.
38. J.W. Eriksson, P. Lonnroth and U. Smith, Vanadate increases cell surface insulin binding and improves insulin sensitivity in both normal and insulin-resistant rat adipocytes, Diabetologia 35 (1992), 510-516.
39. P. Lonroth, J.W. Eriksson, B.I. Posner and U. Smith, Peroxovanadate but not vanadate exerts insulin-like effects in human adipocytes, Diabetologia 36 (1993), 113-166.
40. C.E. Heyliger, A.G. Tahiliani and J.H. McNeill, Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabtetic rats, Science 227 (1985), 1474-1477.
41. J. Gil, M. Miralpeix, J. Carreras and R. Bartrons, Insulin-like effects of vanadate on glucokinase activity and fructose 2,6-bisphosphate levels in the liver of diabetic rats, J. Biol. Chem. 263 (1998), 1868-1871.
42. O. Blondel, J. Simon, B. Chevalier and B. Portha, Impaired insulin action but normal insulin receptor activity in diabetic rat liver: effect of vanadate, Am. J. Physiol. 258 (1990), E459-E467.
43. A. Valera, J.E. Rodriguez-Gil and F. Bosch, Vanadate treatment restores expression of genes for key enzymes in the glucose and ketone bodies metabolism in liver of diabetic rats, J. Clin. Invest. 92 (1993), 4-11.
44. A.K. Saxena, P. Srivastava and N.Z. Baquer, Effect of vanadate on glycolytic enzymes and malic enzyme in insulin-dependent and independent tissues of diabetic rats, Eur. J. Pharmacol. 216 (1992), 123-126.
45. S.M. Brichard, B. Desbuquois and J. Girard, Vanadate treatment of diabetic rats reverses impaired expression of genes involved in hepatic glucose metabolism: effects on glycolytic and gluconeogenic enzymes, and on glucose transporter GLUT2, Mol. Cell. Endocrinol. 91 (1993), 91-97.
46. M. Bollen, M. Miralpeix, F. Ventura, B. Toth, R. Bartrons and W. Stalmans, Oral admnistration of vanadate to streptozotocin-diabetic rats restores the glucose-induced activation of liver glycogen synthase, Biochem. J. 267 (1990), 269-271.
47. L. Rossetti and M.R. Laughlin, Correction of chronic hyperglycemia with vanadate, but not with phlorizin, normalizes in vivo glycogen repletion and in vitro glycogen synthase activity in diabetic skeletal muscle, J. Clin. Invest. 84 (1989), 892-899.
48. M. Bendayan and D. Gingras, Effect of vanadate administration on blood glucose and insulin levels as well as on the exocrine pancreatic function in streptozotocin-diabetic rats, Diabetologia 32 (1989), 561-567.
49. S. Ramanadham, J.J. Mongold, R.W. Brownsey, G.H. Cros and J.H. McNeill, Oral vanadyl sulfate treatment of diabetes mellitus in rats, Am. J. Physiol. 257 (1989), H904-H911.
50. S. Ramanadham, G.H. Cros, J.J. Mongold, J.J. Serrano and J.H. McNeill, Enhanced in vivo sensitivity of vanadyl treated diabetic rats to insulin, Can. J. Physiol. Pharmacol. 68 (1990), 486-491.
51. K.H. Thompson, J.H. McNeilland C. Orvig, Vanadium-containing insulin biomimetic drugs, in: Topics in Biological Inorganic Chemistry, M.J. Clarke and P.J. Sadler, eds, Vol. I, Springer-Verlag, Heidelberg, Germany, in press.
52. E. Tsiani and I.G. Fantus, Vanadium compounds. Biological actions and potential as pharmacalogical agents, Trends Endocrinol. Metab. 8 (1997), 51-58.
53. K.H. Thompson, J. Leichter and J.H. McNeill, Studies of vanadyl sulfate as a glucose-lowering agent in STZ-rats, Biochem. Biophys. Res. Comm. 197 (1993), 1549-1555.
54. K.H. Thompson, V.G. Yuen, J.H. McNeill and C. Orvig, Chemical and pharmacological studies of a new class of antidiabetic vanadium complexes, in: Vanadium Compounds: Chemistry, Biochemistry and Therapeutic Applications, A.S. Tracey and D.C. Crans, eds, ACS Symposium Series 711, ACS, New York, 1998, pp. 329-343.
55. P. Srivastava, A.K. Saxena, R.K. Kale and N.Z. Baquer, Insulin-like effects of lithium and vanadate on the altered antioxidant status of diabetic rats, Res. Comm. Chem. Path. Pharmacol. 80 (1993), 283-293.
56. S. Pugazhenthi, J.F. Angel and R.L. Khandelwal, Does the insulin-mimetic action of vanadate involve insulin receptor kinase?, Mol. Cell. Biochem. 122 (1993), 77-84.
57. G.M. Reaven, Role of insulin resistance in human disease, Ann. Rev. Med. 44 (1993), 121-131.
58. S.M. Brichard, A.M. Pottier and J.C. Henquin, Long term improvement of glucose homeostasis by vanadate in obese hyperinsulinemic Fa/Fa rats, Endocrinology 125 (1989), 2510-2516.
59. S.M. Brichard, F. Assimacopoulos-Jeannet and B. Jeanrenaud, Vanadate treatment markedly increases glucose utilization in muscle of insulin-resistant Fa/Fa rats without modifying glucose transporter expression, Endocrinology 131 (1992), 311-317.
60. S.M. Brichard, C.J. Bailey and J.-C. Henquin, Marked improvement of glucose homeostasis in diabetic ob/ob mice given oral vanadate, Diabetes 39 (1990), 1326-1332.
61. S. Pugazhenthi, J.F. Angel and R.L. Khandelwal, Long-term effects of vanadate treatment on glycogen metabolizing and lipogenic enzymes of liver in genetically diabetic (db/db) mice, Metabolism 40 (1991 ), 941-946.
62. S. Ramanadham, R.W. Brownsey, G.H. Cros, J.J. Mongold and J.H. McNeill, Sustained prevention of myocardial and metabolic abnormalities in diabetic rats following withdrawal from oral vanadyl treatment, Metabolism 38 (1989) 1022-1028.
63. K.H. Thompson and J.H. McNeill, Effect of vanadyl sulfate feeding on susceptibility to peroxidative change in diabetic rats, Res. Comm. Chem. Pathol. Pharmacol. 80 (1993), 187-200.
64. S. Dai, K.H. Thompson and J.H. McNeill, One year treatment of streptozotocin-induced diabetic rats with vanadyl sulphate, Pharmacol. Toxicol. 74 (1994), 101-109.
65. J.W. Lohr, M.I. Bennett, M.A. Pochal, J. McReynolds, M. Acara and G.R. Willsky, Effect of vanadate on renal hypertrophy and sorbitol accumulation in streptozotocin induced diabetes in rats, Res. Comm. Chem. Pathol. Pharmacol. 72 (1991), 191-202.
66. J.J. Mongold, G.H. Cros, L. Vian, A. Tep, S. Ramanadham, G. Siou, J. Diaz, J.H. McNeill and J.J. Serrano, Toxicological aspects of vanadyl sulphate on diabetic rats: effects on vanadium levels and pancreatic β-cell morphology, Pharmacol. Toxicol. 67 (1990), 192-198.
67. J. Meyerovitch, Z. Farfel, J. Sack and Y. Shechter, Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats, J. Biol. Chem. 262 (1987), 6658-6662.
68. S. Dai and J.H. McNeill, One year treatment of non-diabetic and streptozotocin-diabetic rats with vanadyl sulphate did not alter blood pressure or hematological indices, Pharmacol. Toxicol. 74 (1994), 110-115.
69. A.B. Goldfine, D.C. Simonson, F. Folli, M.-E. Patti and C.R. Kahn, Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies, J. Clin. Endocrinol. Metab. 80 (1995), 3311-3320.
70. N. Cohen, M. Halberstam, P. Shlimovich, C.J. Chang, H. Shamoon and L. Rossetti, Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus, J. Clin. Invest. 95 (1995), 2501-2509.
71. G. Boden, X. Chen, J. Ruiz, G.D.V. van Rossum and S. Turco, Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with non-insulin-dependent diabetes mellitus, Metabolism 45 (1996), 1130-1135.
72. A.B. Goldfine, G.R. Willsky and C.R. Kahn, Vanadium salts in the treatment of human diabetes mellitus, in: Vanadium Compounds: Chemistry, Biochemistry and Therapeutic Applications, A.S. Tracey and D.C. Crans, eds, ACS Symposium Series 711, ACS, New York, 1998, pp. 353-367.
73. J.H. McNeill, V.G. Yuen, H.R. Hoveyda and C. Orvig, Bis(maltolato)oxovanadium(IV) is a potent insulin mimic, J. Med. Chem. 35 (1992), 1489-1491.
74. 48V-labeled compounds in rats, J. Appl. Physiol. 84 (1998), 569-575.
75. B.I. Posner, R. Faure, J.W. Burgess, A.P. Bevan, D. Lachance, G. Zhang-Sun, I.G. Fantus, J.B. Ng, D.A. Hall, B. Soo Lum and A. Shaver, Peroxovanadium compounds: a new class of potent phosphotyrosine inhibitors which are insulin mimics, J. Biol. Chem. 269 (1994), 4596-4460.
76. A. Shaver, J.B. Ng, D.A. Hall, B. Soo Lum and B.I. Posner, Insulin mimetic peroxovanadium complexes: preparation and structure of potassium oxodiperoxo(pyridine-2-carboxylato)vanadate(V), and potassium oxodiperoxo(3-hydroxypyridine-2-carboxylato)vanadate(V), and their reactions with cysteine, Inorg. Chem. 32 (1993), 3109-3113.
77. C.M. Krejsa, S.O. Nadler, J.M. Esselstyn, J. Kavanagh, J.A. Ledbetter and G.L. Schieven, Role of oxidative stress in the action of vanadium phosphotyrosine phosphatase inhibitors, J. Biol. Chem. 272 (1997), 11 541-11 549.
78. Y. Shechter, A. Shisheva, R. Lazar, J. Libman and A. Shanzer, Hydrophobic carriers of vanadyl ions augment the insulinomimetic actions of vanadyl ions in rat adipocytes, Biochemistry 31 (1992), 2063-2068.
79. K.H. Thompson, M. Battell and J.H. McNeill, Toxicology of vanadium in mammals, in: Vanadium in the Environment. Part 2. Health Effects, J.O. Nriagu, ed., John Wiley & Sons, New York, 1998, pp. 21-37.
80. H. Sakurai, K. Tsuchiya, M. Nukatsuka, J. Kawada, S. Ishikawa, H. Yoshida and M. Komatsu, Insulin-mimetic action of vanadyl complexes, J. Clin. Biochem. Nutr. 8 (1990) 193-200.
81. M.C. Cam, G.H. Cros, J.-J. Serrano, R. Lazaro and J.H. McNeill, In vivo antidiabetic actions of naglivan, an organic vanadyl compound in streptozotocin-induced diabetes, Diab. Res. Clin. Practice 20 (1993), 111-121.
82. P. Caravan, L. Gelmini, N. Glover, F.G. Herring, H. Li, J.H. McNeill, S.J. Rettig, I.A. Setyawati, E. Shuter, Y. Sun, A.S. Tracey, V.G. Yuen and C. Orvig, Reaction chemistry of BMOV, Bis(maltolato)oxovanadium(IV) - a potent insulin mimetic agent, J Am. Chem. Soc. 117 (1995), 12 759-12 770.
83. S. Fujimoto, K. Fujii, H. Yasui, R. Matsushita, J. Takada and H. Sakurai, Long-term acting and orally active vanadyl-methylpicolinate complex with hypoglycemic activity in streptozotocin-induced diabetic rats, J. Clin. Biochem. Nutr. 23 (1997), 113-129.
84. L. Rossetti, A. Giaccari, E. Klein-Robbenhaar and L.R. Vogel, Insulinomimetic properties of trace elements and characterization of their in vivo mode of action, Diabetes 39 (1990), 1243-1250.
85. A. Shisheva, D. Gefel and Y. Shechter, Insulinlike effects of zinc ion in vitro and in vivo: preferential effects on desensitized adipocytes and induction of normoglycemia in streptozocin-induced rats, Diabetes 41 (1992), 982-988.